题目内容
（请给出正确答案）
[主观题]
New drugs are more risky than old drugs.A．YB．NC．NG
New drugs are more risky than old drugs.
A．Y
B．N
C．NG
答案
查看答案
重要提示：请勿将账号共享给其他人使用，违者账号将被封禁！
查看《购买须知》>>>
请输入或粘贴题目内容
搜题
拍照、语音搜题，请扫码下载APP
题目内容
（请给出正确答案）
New drugs are more risky than old drugs.
A．Y
B．N
C．NG
答案
更多“New drugs are more risky than old drugs.A．YB．NC．NG”相关的问题
第1题
Laurel Woods
A.Prevention should always come before treatment．
B.A new medical treatment needs to be administered with Calltion．
C.Pills often perform. miracles on people who take them．
D.A change of behavior. counts more than reliance on drugs．
E.However good the new drugs，their affordability is first and foremost
F.New drugs shguld nor be put onto the market until proven effective．
G.Drug companies are justified to sell their products at higher
第2题
A．Anti-retro viral drugs are more easily available now.
B．3. 4 million people of working age died of AIDS in 2005.
C．Research of drugs against AIDS has created new jobs.
D．AIDS is undermining the economic growth in many countries.
第3题
John J．Bagshaw
A.Prevention should always come before treatment．
B.A new medical treatment needs to be administered with Calltion．
C.Pills often perform. miracles on people who take them．
D.A change of behavior. counts more than reliance on drugs．
E.However good the new drugs，their affordability is first and foremost
F.New drugs shguld nor be put onto the market until proven effective．
G.Drug companies are justified to sell their products at higher
第4题
Once-daily Pill Could Simplify HIV Treatment
Bristol-Myers Squibb and Gilead Sciences have combined many HIV drugs into a single pill. Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and HIV/ AIDS, for example, are all treated with (51) of drugs. But that can mean a lot of pills to take. It would be (52) if drug companies combined all the medicines into a single pill, taken just once a day.
Now, two companies say they have done that for people just (53) treatment for HIV, the virus, that causes AIDS. The companies are Bristol-Myers Squibb and Gilead Sciences. They have (54) a single pill that combines three drugs currently on the market. Bristol-Myes Squibb sells one of them (55) the name of Sustiva. Gilead combined the (56) , Emtriva and Viread, into a single pill in two thousand four.
Combining drugs involves more than (57) issues. It also involves issues of competition (58) the drugs are made by different companies. The new once-daily pill is the result of (59) is described as the first joint venture agreement of its kind in the treatment of HIV.
In January the New England Journal of Medicine published a study of the new pill. Researchers compared its (60) to that of the widely used combination of Sustiva and Combivir. Combivir (61) two drugs, AZT and 3TC. The researchers say that after one year of treatment, the new pill suppressed HIV levels in more patients and with (62) side effects. Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research.
Glaxo Smith Kine reacted (63) the findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies.
The price of the new once-daily pill has not been announced. But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost to developing countries. They plan in the next few months to ask the United States Food and Drug Administration to (64) the new pill.
There are limits to who could take it because of the different drugs it contains. For example, (65) women are told not to take Sustiva because of the risk of birth disorders. Experts say more that forty million people around the world are living with HIV.
(51)
A．conservation
B．cooperation
C．combinations
D．considerations
第5题
Robert H．Kamm
A.Prevention should always come before treatment．
B.A new medical treatment needs to be administered with Calltion．
C.Pills often perform. miracles on people who take them．
D.A change of behavior. counts more than reliance on drugs．
E.However good the new drugs，their affordability is first and foremost
F.New drugs shguld nor be put onto the market until proven effective．
G.Drug companies are justified to sell their products at higher
第6题
Tom Waken
A.Prevention should always come before treatment．
B.A new medical treatment needs to be administered with Calltion．
C.Pills often perform. miracles on people who take them．
D.A change of behavior. counts more than reliance on drugs．
E.However good the new drugs，their affordability is first and foremost
F.New drugs shguld nor be put onto the market until proven effective．
G.Drug companies are justified to sell their products at higher
第7题
Once Daily Pill Could Simplify HIV Treatment
？？ Bristol-Myers Squibb and Gilead Scienceshave combined many HIV drugs into a single pill. Some- times the best medicineis more than one kind of medicine. Malaria, tuberculosis andHIV/AIDS,___________ (51), are all treated with combinations of drugs. But thatcan mean a lot of pill to take. It wouldbe _______________ (52) drug companiescombined all the medicines into a single pill, taken just once a day.？？
？？ Now,two companies say they have done that for people just ___ (53) treatment for HIV, the virus that causesAIDS. The companies are Bristol-Myers Squibb and Gilead Science. They have ___________(54) a single pill that combinesthree drugs currently on the market. Bristol-Myers Squibb sells one of them___________ (55) the name of Sustiva. Gilead combined the ________________(56), Emtriva and Viread, into a single pill in two thousand four.？？
？？ Combining drugs involves more than _________(57) issues. It alsoinvolves issues of competition _______(58) the drugs are made by different companies. The newonce-daily pill is the result of _________(59) is described as the first joint venture agreement of itskind in the treatment of HIV. In January the New England Journal of Medicinepublished a study of the new pill. Researcher compared its _(60) to that of the widely usedcombination of Sustiva and Combivir. Combivir ________ (61) two drugs, AZT and3TC. The researchers say that after one year of treatment, the n ew pill sup-pressed HIV levels in more patients and with fewer ________________(62)effects. Gilead paid for the study. Professor Joel Gallant at the Johns HopkinsSchool of Medicine in Baltimore, Maryland, led the re- search. He is a paidadviser to Gilead and Bristol-Meyers Squibb as well as the maker of Combivir,G1- axo Smith Kline.？？
？？GlaxoSmith Kline reacted ___(63) the findings by saying that a single study is oflimited value. It says the effectiveness of Combivir has been shown in each ofmore than fifty studies. The price of the new once-daily pill has not been announced.But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost todeveloping countries. They plan in the next few months to ask the United
？？ States Foodand Drug Administr？？ation to approve the new pill.,？？
？？There are limits to who could take it __(64) the different drugs itcontains. For example, __________(65) women are told not to take Sustivabecause of the risk of birth disorders. Experts say more than forty millionpeople around the world are living with HIV.
51？？
A.therefore
B.thus
C.for example
D.nevertheless
第8题
New Attempts to Eradicate AIDS Virus
A high-profile attempt to eradicate the AIDS virus in a few patients continues to show promise.
But researchers won't know for a year or more whether it will work, scientist David Ho told journalists here Wednesday for the Fourth Conference in Viruses and Infections.
"This is a study that's in progress," says Ho, head of the Aaron Diamond AIDS Research Center, New York.
The study involves 20 people who started combinations of anti-HIV drugs very early in the course of the disease, within 90 days of their infections. They've been treated for up to 18 months. Four others have dropped out because of side effects or problems complying with the exacting drug system.
The drugs have knocked the AIDS virus down to undetectable levels in the blood of all remaining patients, s And, in the latest development6, scientists have now tested lymph nodes and semen from a few patients and found no virus reproducing there, Ho says. "Bear in mind that？ undetectable does not equal absent," Ho says.
Ho has calculated that the drugs should be able to wipe out remaining viruses -- at least from known reservoirs throughout the body -- in two to three years. But the only way to prove eradication would be to stop the drugs and see if the virus comes back8. On Wednesday, Ho said he wouldn't ask any patient to consider that step before 2years of treatment.
And he emphasized that he is not urging widespread adoption of such early, aggressive treatment outside of trials9. No one knows the long-term risks.
But other scientists are looking at similar experiments. A federally funded study will put 300 patients on triple-drug treatments and then see if some responding well after six months can continue to suppress the virus on just one or two drugs, says researcher Douglas Richman of the University of California, San Diego. Some patients in that study also may be offered the chance to stop therapy after 18 months or more, he says.
According to the passage, the attempt to eradicate the AIDS virus
A．continues to be hopeful.
B．will be successful in a year.
C．will be successful in future.
D．will stop being hopeful.
第9题
New Attempts to Eradicate AIDS Virus
A high-profile attempt to eradicate the AIDS virus in a few patients continues to show promise.
But researchers won't know for a year or more whether it will work, scientist David Ho told journalists this Wednesday for the Fourth Conference in Viruses and Infections.
"This is a study that's in progress," says Ho, head of the Aaron Diamond AIDS Research Center, New York.
The study involves 20 people who started combinations of anti-HIV drugs very early in the course of the disease, within 90 days of their infections. They've been treated for up to 18 months. Four others have dropped out because of side effects or problems complying with the exacting drug system.
The drugs have knocked the AIDS virus down to undetectable levels in the blood of all remaining patients. And, in the latest development, scientists have now tested lymph nodes and semen from a few patients and found no virus reproducing there, Ho says. "Bear in mind that undetectable does not equal absent," Ho says.
Ho has calculated that the drugs should be able to wipe out remaining viruses--at least from known reservoirs throughout the body--in two to three years. But the only way to prove eradication would be to stop the drugs and see if the virus comes back. On Wednesday, Ho said he wouldn't ask any patient to consider that step before 2 years of treatment.
And he emphasized that he is not urging widespread adoption of such early, aggressive treatment outside of trials. No one knows the long-term risks.
But other scientists are looking at similar experiments. A federally funded study will put 300 patients on triple-drug treatments and then see if some responding well after six months can continue to suppress the virus on just one or two drugs, says researcher Douglas Richman of the University of California, San Diego. Some patients in that study 'also may be offered the chance to stop therapy after 18 months or more, he says.
According to the passage, the attempt to eradicate the AIDS virus
A．continues to be hopeful
B．will be successful in a year
C．will be successful in future
D．will stop being hopeful
第10题
The aim of the agreement is to______.
A．encourage trade in the region.
B．crack down on drug smuggling.
C．save the declining fishing industry.
D．strengthen cross-boarder police presence.
